Home LiteratureArticle Details
PMID: 1850003 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.

Journal of virology ·Vol. 65 ·No. 5 ·1991-05-00 ·Pages 2164-9

Sung NS, Kenney S, Gutsch D, Pagano JS

Abstract

Among the few Epstein-Barr virus (EBV) genes expressed during latency are the Epstein-Barr nuclear antigens (EBNAs), at least one of which contributes to the ability of the virus to transform B lymphocytes. We have analyzed a promoter located in the BamHI-C fragment of EBV which is responsible for the expression of EBNA-1 in some cell lines. Deletion analysis of a 1.4-kb region 5' of the RNA start site has identified a 700-bp fragment that is required for optimal promoter activity in latently infected B lymphocytes, as shown by promoter constructs linked to the chloramphenicol acetyltransferase reporter gene. This fragment is also able to enhance activity, in an orientation-independent manner, of the simian virus 40 early promoter linked to the chloramphenicol acetyltransferase gene. The enhancer element has some constitutive activity in EBV-negative lymphoid cells, which is increased in the presence of the EBNA-2 gene product. Further deletions have shown that the EBNA-2-responsive region requires a 98-bp region that contains a degenerate octamer-binding motif. In epithelial cells there was no enhancer activity regardless of the presence of EBNA-2. These results demonstrate that BamHI-C promoter activity may be dependent not on an enhancer contained in the ori-P, as was previously assumed, but rather on EBNA-2 transactivation of this more proximal enhancer located in the upstream region of the BamHI C promoter itself.

MeSH Terms
Antigens, Viral/genetics,metabolism Base Sequence Cell Line Cloning, Molecular DNA, Viral/genetics,metabolism Deoxyribonuclease BamHI/metabolism Enhancer Elements, Genetic Epstein-Barr Virus Nuclear Antigens Herpesvirus 4, Human/genetics,immunology Humans Molecular Sequence Data Promoter Regions, Genetic RNA, Viral/metabolism Sequence Homology, Nucleic Acid Transcriptional Activation Transfection Tumor Cells, Cultured
Chemicals
Antigens, Viral DNA, Viral Epstein-Barr Virus Nuclear Antigens RNA, Viral Deoxyribonuclease BamHI
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sung N S
Department of Microbiology, University of North Carolina, Chapel Hill 27514.
Kenney S
Gutsch D
Pagano J S
References (49)
49 references, click to expand
  1. A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.
    J Clin Pathol. 1965 May;18:261-73 PMID: 14304234
  2. Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.
    J Virol. 1982 Sep;43(3):979-86 PMID: 6292475
  3. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6498-502 PMID: 2549539
  4. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    J Virol. 1989 Apr;63(4):1531-9 PMID: 2538644
  5. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.
    J Virol. 1987 Nov;61(11):3424-30 PMID: 2822952
  6. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Mol Cell Biol. 1986 Nov;6(11):3838-46 PMID: 3025615
  7. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1987 Dec;84(23):8642-6 PMID: 2825201
  8. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4 PMID: 2825176
  9. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  10. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  11. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
    Nucleic Acids Res. 1988 Sep 12;16(17):8391-410 PMID: 2843816
  12. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.
    J Virol. 1986 Aug;59(2):453-62 PMID: 2426468
  13. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5096-100 PMID: 3460083
  14. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  15. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.
    J Virol. 1989 Jun;63(6):2644-9 PMID: 2542577
  16. A 100-kD HeLa cell octamer binding protein (OBP100) interacts differently with two separate octamer-related sequences within the SV40 enhancer.
    Genes Dev. 1987 Dec;1(10):1147-60 PMID: 2828167
  17. Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation.
    Cell. 1988 Feb 12;52(3):435-45 PMID: 2830987
  18. Differentiation and DNA contact points of host proteins binding at the cis site for virion-mediated induction of alpha genes of herpes simplex virus 1.
    J Virol. 1988 Apr;62(4):1145-57 PMID: 2831377
  19. OBP100 binds remarkably degenerate octamer motifs through specific interactions with flanking sequences.
    Genes Dev. 1988 Nov;2(11):1400-13 PMID: 2850260
  20. A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins.
    Proc Natl Acad Sci U S A. 1988 Sep;85(17):6347-51 PMID: 2842768
  21. An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9298-302 PMID: 3025831
  22. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.
    Int J Cancer. 1987 Jan 15;39(1):25-9 PMID: 3025109
  23. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    J Natl Cancer Inst. 1985 Jan;74(1):57-60 PMID: 2982054
  24. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.
    J Virol. 1985 Aug;55(2):286-97 PMID: 2991556
  25. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes.
    Nature. 1986 Oct 16-22;323(6089):640-3 PMID: 3095662
  26. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
    Nature. 1986 Jan 9-15;319(6049):154-8 PMID: 3079885
  27. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines.
    J Virol. 1989 Sep;63(9):4079-84 PMID: 2548016
  28. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
    J Virol. 1989 Apr;63(4):1729-36 PMID: 2538653
  29. Sequences closely related to an immunoglobulin gene promoter/enhancer element occur also upstream of other eukaryotic and of prokaryotic genes.
    Nucleic Acids Res. 1986 Nov 25;14(22):8819-27 PMID: 3537963
  30. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    J Virol. 1990 Jun;64(6):2530-6 PMID: 2159528
  31. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    J Virol. 1990 May;64(5):2126-34 PMID: 2157875
  32. cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.
    J Virol. 1990 Apr;64(4):1855-8 PMID: 2157069
  33. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    J Virol. 1990 Jul;64(7):3407-16 PMID: 2352328
  34. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Proc Natl Acad Sci U S A. 1990 Mar;87(5):1725-9 PMID: 2155423
  35. Gene transfer into mouse lyoma cells by electroporation in high electric fields.
    EMBO J. 1982;1(7):841-5 PMID: 6329708
  36. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    J Virol. 1980 Nov;36(2):506-18 PMID: 6253674
  37. Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence.
    Proc Natl Acad Sci U S A. 1984 May;81(9):2650-4 PMID: 6425835
  38. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.
    J Virol. 1984 Jan;49(1):183-9 PMID: 6690710
  39. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  40. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma.
    Proc Natl Acad Sci U S A. 1973 Nov;70(11):3265-8 PMID: 4361687
  41. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells.
    Nat New Biol. 1972 Aug 9;238(84):169-71 PMID: 4340572
  42. Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya.
    Int J Cancer. 1975 Jul 15;16(1):7-15 PMID: 170215
  43. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  44. Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.
    Proc Natl Acad Sci U S A. 1982 Nov;79(21):6453-7 PMID: 6292901
  45. Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.
    Methods Enzymol. 1980;65(1):718-49 PMID: 6154876
  46. Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.
    Proc Natl Acad Sci U S A. 1981 Mar;78(3):1930-4 PMID: 6112750
  47. Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements.
    Nature. 1984 Jul 5-11;310(5972):71-4 PMID: 6330567
  48. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.
    J Virol. 1982 Dec;44(3):834-44 PMID: 6294333
  49. The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.
    J Virol. 1989 Sep;63(9):3870-7 PMID: 2548002
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1991-05-00
Pages
2164-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC240563
Subset
IM
Grants
NCI NIH HHS · P01-CA19014-12 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]